Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC [Phase 2]
A Phase 2 clinical trial is evaluating a PD-1 antibody in combination with Sapropterin Dihydrochloride for metastatic pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating CEP-37250/KHK2804 in adults with advanced solid tumors has completed; the conditions include colorectal adenocarcin…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment [Phase 3]
Phase 3 study evaluating irinotecan liposome injection with 5-FU/leucovorin and oxaliplatin versus nab-paclitaxel plus gemcitabine in previo…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]
A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular …
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer [Phase 1, Phase 2]
Early-phase clinical trial update evaluating fluorescent navigation technology to aid radical resection in resectable pancreatic adenocarcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride with radiation therapy for borderline resectable pancreatic cancer (terminated; results p…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial investigating durvalumab with booster radiation in metastatic pancreatic adenocarcinoma was terminated; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. [Phase 1, Phase 2]
Phase 1/2 trial update for MEDI9447 (oleclumab) in combination with pancreatic chemotherapy in metastatic pancreatic adenocarcinoma; study c…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating nab-paclitaxel and gemcitabine followed by AG-mFOLFOX in metastatic pancreatic adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") [Phase 2]
Phase 2 clinical trial exploring molecular profiling to guide therapy before and after surgery in pancreatic adenocarcinoma; results complet…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy [Phase 1, Phase 2]
Phase 1/2 study evaluating Niraparib in combination with Ipilimumab or Nivolumab in pancreatic adenocarcinoma after platinum-based chemother…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating ramucirumab with nab-paclitaxel and gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial investigating BATS with low-dose IL-1 and GM-CSF in advanced pancreatic cancer (Phase 1/2) has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 trial assessing paclitaxel albumin-stabilized nanoparticles with or without AZD1775 in previously untreated metastatic or unresect…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update on intratumoral gene therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]
A Phase 3 trial comparing EndoTAG-1+GEM versus GEM in locally advanced or metastatic pancreatic adenocarcinoma after FOLFIRINOX failure has …
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for durvalumab plus CV301 with maintenance chemotherapy in metastatic colorectal or pancreatic adenocarcinoma; study s…
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas [Phase 3]
Phase 3 trial comparing FFX to CPI-613 with mFFX in metastatic pancreatic adenocarcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer [NA]
A clinical trial evaluating a radiopaque hydrogel used during radiotherapy for pancreatic adenocarcinoma has completed, and results have bee…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating interim 18F-FLT PET/CT to predict outcomes in pancreatic adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial update on neoadjuvant modified FOLFIRINOX with stereotactic body radiation therapy in borderline resectable pancreatic adenoca…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC [Phase 3]
Phase 3 study evaluating Eryaspase plus chemotherapy versus chemotherapy alone as second-line treatment for pancreatic adenocarcinoma has co…
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial assessing APX005M with gemcitabine and nab-paclitaxel, with or without nivolumab, in previously untreated metastatic pancrea…